Acerus Pharmaceuticals GAAP EPS of -$0.54, revenue of $0.77M

Stock Information for Acerus Pharmaceuticals Corp Ordinary Shares

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Acerus Pharmaceuticals Corp Ordinary Shares

Acerus Update
Acerus Update
Acerus Announces Commencement of Court-Approved Sale and Investment Solicitation Process
Acerus Files For CCAA Protection
Acerus Announces Resignation of Director
Acerus Announces New Loan Agreement With First Generation Capital
Acerus Reports Third Quarter 2022 Financial Results
Acerus Announces Amendment to Promissory Note Due to Former Serenity Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.